Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1991;11:892-902

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bjorkerud, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bjorkerud, S.

Arteriosclerosis and Thrombosis, Vol 11, 892-902, Copyright © 1991 by American Heart Association


ARTICLES

Effects of transforming growth factor-beta 1 on human arterial smooth muscle cells in vitro

S Bjorkerud
Department of Pathology I, University of Gothenburg, Sweden.

Control of the thickness of the arterial wall is critical, as excessive overgrowth of constituent smooth muscle cells (SMCs) may interfere with blood flow. Effects on SMCs in vitro of several growth factors that are present in blood and/or that are produced endogenously in the arterial wall under certain conditions suggest that influences of endocrine, paracrine, and autocrine nature from stimulating and inhibiting factors may control the smooth muscle tissue mass in the artery. This possibility was explored further by investigating the degree of myodifferentiation in terms of the presence of differentiation-specific filamentous alpha-smooth muscle actin and growth, as measured by the synthesis of DNA and cell number, of SMCs as influenced by their exposure to the mitogens, platelet-derived growth factor and epidermal growth factor, and the bifunctional growth factor, transforming growth factor-beta 1 (TGF-beta 1). Exposure to TGF-beta 1 markedly enhanced differentiation-specific filamentous alpha-smooth muscle actin. This effect did not require arrest of growth, which speaks against a direct causal relation between loss of myodifferentiation (modulation) and multiplication. When quiescent cultures were exposed to TGF-beta 1, alpha-smooth muscle actin was further increased, indicating a more specific differentiation-promoting effect by TGF-beta 1 than mere inhibition of growth. Exposure to TGF-beta 1 also increased spreading, which occurred in parallel with increased filamentous alpha-smooth muscle actin and appearance of stress fibers. Exposure to platelet- derived growth factor under serum-free conditions and to epidermal growth factor in cultures exposed to serum markedly decreased the number of alpha-actin-positive SMCs, indicating a dedifferentiating effect by these mitogens. Exposure of SMCs to TGF-beta 1 under serum- free conditions had pronounced effects on growth, with a concentration- dependent inhibition of platelet-derived growth factor-induced DNA synthesis and cell multiplication. The basal synthesis of DNA in the absence of added growth factors was also greatly inhibited. With serum- free cultures, some loss of cells occurred even with very low concentrations of TGF-beta 1 (5 pg/ml), against which platelet-derived growth factor or a dense cultural state had a protective effect. Enhancement of cell multiplication was not detected for cultivated human SMCs exposed to TGF-beta 1, irrespective of culture density, in contrast to that reported for dense cultures of rat SMCs. TGF-beta 1 is present in and may be released from platelets in situations that promote platelet adherence such as endothelial injury; TGF-beta 1 may also be released from activated macrophages and T lymphocytes either during an immune reaction or inflammation or from the endothelium.(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
StrokeHome page
P. T.G. Bot, I. E. Hoefer, J. P.G. Sluijter, P. van Vliet, A. M. Smits, F. Lebrin, F. Moll, J.-P. de Vries, P. Doevendans, J. J. Piek, et al.
Increased Expression of the Transforming Growth Factor-{beta} Signaling Pathway, Endoglin, and Early Growth Response-1 in Stable Plaques
Stroke, February 1, 2009; 40(2): 439 - 447.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
Z. Gong and L. E. Niklason
Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs)
FASEB J, June 1, 2008; 22(6): 1635 - 1648.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Korff, K. Aufgebauer, and M. Hecker
Cyclic Stretch Controls the Expression of CD40 in Endothelial Cells by Changing Their Transforming Growth Factor-{beta}1 Response
Circulation, November 13, 2007; 116(20): 2288 - 2297.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. J. Grainger
TGF-{beta} and atherosclerosis in man
Cardiovasc Res, May 1, 2007; 74(2): 213 - 222.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. D. Jarvis, M. T. Rademaker, L. J. Ellmers, M. J. Currie, J. L. McKenzie, B. R. Palmer, C. M. Frampton, A. M. Richards, and V. A. Cameron
Comparison of infarct-derived and control ovine cardiac myofibroblasts in culture: response to cytokines and natriuretic peptide receptor expression profiles.
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1952 - H1958.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Otsuka, R. Agah, A. D. Frutkin, T. N. Wight, and D. A. Dichek
Transforming Growth Factor Beta 1 Induces Neointima Formation Through Plasminogen Activator Inhibitor-1-Dependent Pathways
Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 737 - 743.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
A. M. Goldsmith, J. K. Bentley, L. Zhou, Y. Jia, K. N. Bitar, D. C. Fingar, and M. B. Hershenson
Transforming Growth Factor-beta Induces Airway Smooth Muscle Hypertrophy
Am. J. Respir. Cell Mol. Biol., February 1, 2006; 34(2): 247 - 254.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. Deaton, C. Su, T. G. Valencia, and S. R. Grant
Transforming Growth Factor-{beta}1-induced Expression of Smooth Muscle Marker Genes Involves Activation of PKN and p38 MAPK
J. Biol. Chem., September 2, 2005; 280(35): 31172 - 31181.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K.-G. Shyu, Y.-M. Chao, B.-W. Wang, and P. Kuan
Regulation of Discoidin Domain Receptor 2 by Cyclic Mechanical Stretch in Cultured Rat Vascular Smooth Muscle Cells
Hypertension, September 1, 2005; 46(3): 614 - 621.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Sinha, M. H. Hoofnagle, P. A. Kingston, M. E. McCanna, and G. K. Owens
Transforming growth factor-{beta}1 signaling contributes to development of smooth muscle cells from embryonic stem cells
Am J Physiol Cell Physiol, December 1, 2004; 287(6): C1560 - C1568.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. G. Elliot, C. M. Jensen, S. Mutavdzic, J. P. Lamb, N. G. Carroll, and A. L. James
Aggregations of Lymphoid Cells in the Airways of Nonsmokers, Smokers, and Subjects with Asthma
Am. J. Respir. Crit. Care Med., March 15, 2004; 169(6): 712 - 718.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. J. Grainger
Transforming Growth Factor {beta} and Atherosclerosis: So Far, So Good for the Protective Cytokine Hypothesis
Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 399 - 404.
[Abstract] [Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. Mori, H. Kida, H. Morishita, S. Goya, H. Matsuoka, T. Arai, T. Osaki, I. Tachibana, S. Yamamoto, M. Sakatani, et al.
Microsatellite Instability in Transforming Growth Factor-{beta}1 Type II Receptor Gene in Alveolar Lining Epithelial Cells of Idiopathic Pulmonary Fibrosis
Am. J. Respir. Cell Mol. Biol., April 1, 2001; 24(4): 398 - 404.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
X. Ma, M. Labinaz, J. Goldstein, H. Miller, W. J. Keon, M. Letarte, and E. O'Brien
Endoglin Is Overexpressed After Arterial Injury and Is Required for Transforming Growth Factor-{beta}-Induced Inhibition of Smooth Muscle Cell Migration
Arterioscler Thromb Vasc Biol, December 1, 2000; 20(12): 2546 - 2552.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A.-C. Desfaits, J. Raymond, and J. P. Muizelaar
Growth Factors Stimulate Neointimal Cells In Vitro and Increase the Thickness of the Neointima Formed at the Neck of Porcine Aneurysms Treated by Embolization • Editorial Comment
Stroke, February 1, 2000; 31(2): 498 - 507.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
D. Grainger, D. Mosedale, J. Metcalfe, and E. Bottinger
Dietary fat and reduced levels of TGFbeta1 act synergistically to promote activation of the vascular endothelium and formation of lipid lesions
J. Cell Sci., January 7, 2000; 113(13): 2355 - 2361.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
J. B. Hoying, M. Yin, R. Diebold, I. Ormsby, A. Becker, and T. Doetschman
Transforming Growth Factor beta 1 Enhances Platelet Aggregation through a Non-transcriptional Effect on the Fibrinogen Receptor
J. Biol. Chem., October 22, 1999; 274(43): 31008 - 31013.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Abe, N. Iehara, K. Utsunomiya, T. Kita, and T. Doi
A Vitamin D Analog Regulates Mesangial Cell Smooth Muscle Phenotypes in a Transforming Growth Factor-beta Type II Receptor-mediated Manner
J. Biol. Chem., July 23, 1999; 274(30): 20874 - 20878.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Christen, M.-L. Bochaton-Piallat, P. Neuville, S. Rensen, M. Redard, G. van Eys, and G. Gabbiani
Cultured Porcine Coronary Artery Smooth Muscle Cells : A New Model With Advanced Differentiation
Circ. Res., July 9, 1999; 85(1): 99 - 107.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. D. Arora, N. Narani, and C. A. G. McCulloch
The Compliance of Collagen Gels Regulates Transforming Growth Factor-ß Induction of {alpha}-Smooth Muscle Actin in Fibroblasts
Am. J. Pathol., March 1, 1999; 154(3): 871 - 882.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. M. Romanic, A. J. Arleth, R. N. Willette, and E. H. Ohlstein
Factor XIIIa Cross-links Lipoprotein(a) With Fibrinogen and Is Present in Human Atherosclerotic Lesions
Circ. Res., August 10, 1998; 83(3): 264 - 269.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. McKay, J. C. de Jongste, P. R. Saxena, and H. S. Sharma
Angiotensin II Induces Hypertrophy of Human Airway Smooth Muscle Cells: Expression of Transcription Factors and Transforming Growth Factor-beta 1
Am. J. Respir. Cell Mol. Biol., June 1, 1998; 18(6): 823 - 833.
[Abstract] [Full Text]


Home page
CirculationHome page
S. S. Patel, R. Thiagarajan, J. T. Willerson, and E. T. H. Yeh
Inhibition of {alpha}4 Integrin and ICAM-1 Markedly Attenuate Macrophage Homing to Atherosclerotic Plaques in ApoE-Deficient Mice
Circulation, January 13, 1998; 97(1): 75 - 81.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
D. Grainger, J. Metcalfe, A. Grace, and D. Mosedale
Transforming growth factor-beta dynamically regulates vascular smooth muscle differentiation in vivo
J. Cell Sci., January 10, 1998; 111(19): 2977 - 2988.
[Abstract] [PDF]


Home page
Circ. Res.Home page
M. B. Hautmann, M. M. Thompson, E. A. Swartz, E. N. Olson, and G. K. Owens
Angiotensin II–Induced Stimulation of Smooth Muscle {alpha}-Actin Expression by Serum Response Factor and the Homeodomain Transcription Factor MHox
Circ. Res., October 19, 1997; 81(4): 600 - 610.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. B. Hautmann, C. S. Madsen, and G. K. Owens
A Transforming Growth Factor beta (TGFbeta ) Control Element Drives TGFbeta -induced Stimulation of Smooth Muscle alpha -Actin Gene Expression in Concert with Two CArG Elements
J. Biol. Chem., April 18, 1997; 272(16): 10948 - 10956.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Reckless, J. C. Metcalfe, and D. J. Grainger
Tamoxifen Decreases Cholesterol Sevenfold and Abolishes Lipid Lesion Development in Apolipoprotein E Knockout Mice
Circulation, March 18, 1997; 95(6): 1542 - 1548.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Waltenberger, M. L. Akyurek, M. Aurivillius, A. Wanders, E. Larsson, B. Fellstrom, and K. Funa
Ischemia-Induced Transplant Arteriosclerosis in the Rat: Induction of Peptide Growth Factor Expression
Arterioscler Thromb Vasc Biol, December 1, 1996; 16(12): 1516 - 1523.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Bjorkerud and S. Bjorkerud
Contrary Effects of Lightly and Strongly Oxidized LDL With Potent Promotion of Growth Versus Apoptosis on Arterial Smooth Muscle Cells, Macrophages, and Fibroblasts
Arterioscler Thromb Vasc Biol, March 1, 1996; 16(3): 416 - 424.
[Abstract] [Full Text]


Home page
ScienceHome page
D. Grainger, H. Kirschenlohr, J. Metcalfe, P. Weissberg, D. Wade, and R. Lawn
Proliferation of human smooth muscle cells promoted by lipoprotein(a)
Science, June 11, 1993; 260(5114): 1655 - 1658.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
E. Arciniegas, A. B. Sutton, T. D. Allen, and A. M. Schor
Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro
J. Cell Sci., October 1, 1992; 103(2): 521 - 529.
[Abstract] [PDF]